ReviewFrontiers in pharmacology2025
Endoplasmic reticulum stress and exosomes secretion in the pathogenesis of inflammatory bowel disease: a concise summary of research findings.
Review in Frontiers in pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Depleting luminal cysteine with engineered bacteroides vulgatus alleviates experimental colitis by suppressing Th17 differentiation through an ATF6-dependent mechanism.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2026Article
- Probiotic-Derived Extracellular Vesicles as Potential Nano-Immunotherapeutic Platforms in IBD: A Clinician's Perspective.International journal of nanomedicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cellular stress responses and intercellular communication play a crucial role in the pathogenesis of Inflammatory bowel disease (IBD). Among these, endoplasmic reticulum (ER) stress and exosome-mediated signaling have emerged as interconnected drivers of chronic intestinal inflammation. Persistent ER stress, primarily through unfolded protein response pathways involving PERK, IRE1, and ATF6, disrupts epithelial barrier integrity, alters immune cell function, and promotes pro-inflammatory gene expression. ER stress not only affects intracellular homeostasis but also modulates intercellular communication through the secretion of exosomes, which carry proteins, lipids, and nucleic acids. This bidirectional relationship ensures that stress-altered exosomes can amplify ER stress and inflammatory signals in neighboring cells, sustaining intestinal inflammation. For this review, relevant research and review articles were retrieved from established search engines and databases, including PubMed, Google Scholar, and ScienceDirect, using key terms such as "endoplasmic reticulum stress," "exosome secretion," "exosome cargo," "inflammatory bowel disease," "intestinal inflammation," and "intercellular communication." The literature search primarily focused on studies published in the last 5 years, prioritizing clinical and preclinical studies (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.